4D Molecular Therapeutics Inc (FDMT)
7.99
-0.42
(-4.99%)
USD |
NASDAQ |
Nov 21, 16:00
7.975
-0.02
(-0.19%)
Pre-Market: 20:00
4D Molecular Therapeutics Total Assets (Quarterly): 604.03M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 604.03M |
| June 30, 2024 | 620.12M |
| March 31, 2024 | 629.88M |
| December 31, 2023 | 339.89M |
| September 30, 2023 | 361.61M |
| June 30, 2023 | 352.50M |
| March 31, 2023 | 244.02M |
| December 31, 2022 | 261.85M |
| September 30, 2022 | 280.16M |
| June 30, 2022 | 302.94M |
| Date | Value |
|---|---|
| March 31, 2022 | 324.93M |
| December 31, 2021 | 353.49M |
| September 30, 2021 | 240.62M |
| June 30, 2021 | 254.93M |
| March 31, 2021 | 270.11M |
| December 31, 2020 | 288.33M |
| September 30, 2020 | 98.19M |
| December 31, 2019 | 58.23M |
| June 30, 2019 | 80.50M |
| December 31, 2018 | 96.97M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
58.23M
Minimum
Dec 2019
629.88M
Maximum
Mar 2024
326.99M
Average
295.63M
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 37.44B |
| Ocular Therapeutix Inc | 490.37M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 51.08M |
| Shareholders Equity (Quarterly) | 552.95M |
| Current Ratio | 17.33 |